Bodal Chemicals Limited Logo

Bodal Chemicals Limited

BODALCHEM.NS

(2.0)
Stock Price

73,74 INR

0.14% ROA

0.29% ROE

331.34x PER

Market Cap.

10.234.209.440,00 INR

77.81% DER

0% Yield

0.21% NPM

Bodal Chemicals Limited Stock Analysis

Bodal Chemicals Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Bodal Chemicals Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

4 ROE

The stock's ROE falls within an average range (7.59%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (4.442), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

6 ROA

The stock's ROA (0%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

11 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Bodal Chemicals Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Bodal Chemicals Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Bodal Chemicals Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Bodal Chemicals Limited Revenue
Year Revenue Growth
2005 1.468.130.000
2006 2.541.740.000 42.24%
2007 4.048.839.000 37.22%
2008 3.954.862.000 -2.38%
2009 4.675.450.000 15.41%
2010 5.596.097.000 16.45%
2011 6.137.060.000 8.81%
2012 5.295.892.000 -15.88%
2013 9.595.161.000 44.81%
2014 10.358.048.000 7.37%
2015 9.099.550.000 -13.83%
2016 12.362.970.000 26.4%
2017 11.302.660.000 -9.38%
2018 13.988.490.000 19.2%
2019 13.617.090.000 -2.73%
2020 12.209.290.000 -11.53%
2021 20.267.840.000 39.76%
2022 15.742.800.000 -28.74%
2023 13.199.960.000 -19.26%
2023 13.946.210.000 5.35%
2024 16.878.480.000 17.37%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Bodal Chemicals Limited Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 15.710.000 100%
2016 18.910.000 16.92%
2017 20.640.000 8.38%
2018 29.550.000 30.15%
2019 36.210.000 18.39%
2020 40.130.000 9.77%
2021 49.480.000 18.9%
2022 44.130.000 -12.12%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Bodal Chemicals Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 18.578.000
2006 24.069.000 22.81%
2007 37.749.000 36.24%
2008 248.813.000 84.83%
2009 74.040.000 -236.05%
2010 111.849.000 33.8%
2011 166.912.000 32.99%
2012 808.598.000 79.36%
2013 134.736.000 -500.14%
2014 121.170.000 -11.2%
2015 25.709.000 -371.31%
2016 36.320.000 29.22%
2017 40.130.000 9.49%
2018 47.430.000 15.39%
2019 104.150.000 54.46%
2020 115.520.000 9.84%
2021 146.020.000 20.89%
2022 120.190.000 -21.49%
2023 0 0%
2023 0 0%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Bodal Chemicals Limited EBITDA
Year EBITDA Growth
2005 100.372.000
2006 203.588.000 50.7%
2007 421.152.000 51.66%
2008 46.116.000 -813.24%
2009 529.689.000 91.29%
2010 612.231.000 13.48%
2011 48.874.000 -1152.67%
2012 202.448.000 75.86%
2013 2.604.557.000 92.23%
2014 1.840.374.000 -41.52%
2015 1.582.441.000 -16.3%
2016 2.292.840.000 30.98%
2017 2.020.550.000 -13.48%
2018 2.465.830.000 18.06%
2019 1.477.420.000 -66.9%
2020 1.145.260.000 -29%
2021 2.301.450.000 50.24%
2022 1.449.530.000 -58.77%
2023 1.176.480.000 -23.21%
2023 1.106.830.000 -6.29%
2024 1.475.640.000 24.99%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Bodal Chemicals Limited Gross Profit
Year Gross Profit Growth
2005 319.167.000
2006 521.957.000 38.85%
2007 888.727.000 41.27%
2008 891.606.000 0.32%
2009 1.448.925.000 38.46%
2010 1.146.754.000 -26.35%
2011 852.079.000 -34.58%
2012 1.550.416.000 45.04%
2013 2.662.698.000 41.77%
2014 2.830.549.000 5.93%
2015 3.393.867.000 16.6%
2016 4.389.730.000 22.69%
2017 3.434.290.000 -27.82%
2018 4.109.510.000 16.43%
2019 3.721.780.000 -10.42%
2020 3.291.570.000 -13.07%
2021 5.420.310.000 39.27%
2022 6.704.380.000 19.15%
2023 6.331.200.000 -5.89%
2023 5.318.750.000 -19.04%
2024 6.071.840.000 12.4%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Bodal Chemicals Limited Net Profit
Year Net Profit Growth
2005 24.362.000
2006 111.701.000 78.19%
2007 174.500.000 35.99%
2008 -111.360.000 256.7%
2009 134.637.000 182.71%
2010 175.387.000 23.23%
2011 298.340.000 41.21%
2012 -232.400.000 228.37%
2013 301.628.000 177.05%
2014 917.824.000 67.14%
2015 859.866.000 -6.74%
2016 1.285.840.000 33.13%
2017 1.225.600.000 -4.92%
2018 1.431.990.000 14.41%
2019 871.640.000 -64.29%
2020 419.820.000 -107.62%
2021 1.042.280.000 59.72%
2022 380.330.000 -174.05%
2023 49.760.000 -664.33%
2023 64.690.000 23.08%
2024 -47.000.000 237.64%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Bodal Chemicals Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 2 100%
2007 2 0%
2008 -1 300%
2009 1 200%
2010 2 0%
2011 -3 150%
2012 -2 0%
2013 3 200%
2014 8 75%
2015 8 -14.29%
2016 12 41.67%
2017 11 -20%
2018 12 9.09%
2019 7 -57.14%
2020 3 -133.33%
2021 9 62.5%
2022 3 -166.67%
2023 0 0%
2023 1 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Bodal Chemicals Limited Free Cashflow
Year Free Cashflow Growth
2005 -67.936.000
2006 -287.418.000 76.36%
2007 -547.434.000 47.5%
2008 97.021.000 664.24%
2009 -704.841.000 113.76%
2010 -518.145.000 -36.03%
2011 -229.325.000 -125.94%
2012 97.107.000 336.16%
2013 339.827.000 71.42%
2014 1.622.537.000 79.06%
2015 1.068.212.000 -51.89%
2016 540.270.000 -97.72%
2017 -2.213.740.000 124.41%
2018 377.290.000 686.75%
2019 -425.380.000 188.69%
2020 -1.911.431.000 77.75%
2021 -1.726.020.000 -10.74%
2022 -528.490.000 -226.59%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Bodal Chemicals Limited Operating Cashflow
Year Operating Cashflow Growth
2005 -56.044.000
2006 -204.687.000 72.62%
2007 142.934.000 243.2%
2008 319.458.000 55.26%
2009 174.348.000 -83.23%
2010 472.205.000 63.08%
2011 -199.000 237388.94%
2012 152.000.000 100.13%
2013 521.859.000 70.87%
2014 1.977.159.000 73.61%
2015 1.312.272.000 -50.67%
2016 1.129.270.000 -16.21%
2017 70.830.000 -1494.34%
2018 1.859.710.000 96.19%
2019 95.590.000 -1845.51%
2020 -130.171.000 173.43%
2021 -135.200.000 3.72%
2022 2.849.100.000 104.75%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Bodal Chemicals Limited Capital Expenditure
Year Capital Expenditure Growth
2005 11.892.000
2006 82.731.000 85.63%
2007 690.368.000 88.02%
2008 222.437.000 -210.37%
2009 879.189.000 74.7%
2010 990.350.000 11.22%
2011 229.126.000 -332.23%
2012 54.893.000 -317.4%
2013 182.032.000 69.84%
2014 354.622.000 48.67%
2015 244.060.000 -45.3%
2016 589.000.000 58.56%
2017 2.284.570.000 74.22%
2018 1.482.420.000 -54.11%
2019 520.970.000 -184.55%
2020 1.781.260.000 70.75%
2021 1.590.820.000 -11.97%
2022 3.377.590.000 52.9%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Bodal Chemicals Limited Equity
Year Equity Growth
2005 281.092.000
2006 357.226.000 21.31%
2007 472.793.000 24.44%
2008 507.243.000 6.79%
2009 578.775.000 12.36%
2010 796.426.000 27.33%
2011 584.464.000 -36.27%
2012 508.447.000 -14.95%
2013 898.930.000 43.44%
2014 1.814.907.000 50.47%
2015 2.345.982.000 22.64%
2016 3.610.210.000 35.02%
2017 6.980.800.000 48.28%
2018 8.302.860.000 15.92%
2019 9.366.990.000 11.36%
2020 9.799.080.000 4.41%
2021 10.523.510.000 6.88%
2022 10.777.030.000 2.35%
2023 10.822.410.000 0.42%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Bodal Chemicals Limited Assets
Year Assets Growth
2005 929.196.000
2006 1.690.304.000 45.03%
2007 2.939.083.000 42.49%
2008 3.260.066.000 9.85%
2009 4.466.240.000 27.01%
2010 5.511.923.000 18.97%
2011 5.748.438.000 4.11%
2012 4.764.354.000 -20.66%
2013 5.926.577.000 19.61%
2014 5.342.350.000 -10.94%
2015 5.098.830.000 -4.78%
2016 6.975.430.000 26.9%
2017 10.749.990.000 35.11%
2018 12.986.580.000 17.22%
2019 14.695.470.000 11.63%
2020 17.477.590.000 15.92%
2021 21.223.110.000 17.65%
2022 21.209.000.000 -0.07%
2023 22.878.800.000 7.3%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Bodal Chemicals Limited Liabilities
Year Liabilities Growth
2005 648.104.000
2006 1.333.078.000 51.38%
2007 2.466.290.000 45.95%
2008 2.752.823.000 10.41%
2009 3.887.465.000 29.19%
2010 4.715.497.000 17.56%
2011 5.163.974.000 8.68%
2012 4.255.907.000 -21.34%
2013 5.027.647.000 15.35%
2014 3.527.443.000 -42.53%
2015 2.752.848.000 -28.14%
2016 3.365.220.000 18.2%
2017 3.769.190.000 10.72%
2018 4.683.720.000 19.53%
2019 5.328.480.000 12.1%
2020 7.678.510.000 30.61%
2021 10.699.600.000 28.24%
2022 10.431.970.000 -2.57%
2023 12.056.390.000 13.47%

Bodal Chemicals Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
117.98
Net Income per Share
0.25
Price to Earning Ratio
331.34x
Price To Sales Ratio
0.69x
POCF Ratio
11.75
PFCF Ratio
11.77
Price to Book Ratio
0.94
EV to Sales
1.24
EV Over EBITDA
13.51
EV to Operating CashFlow
21.13
EV to FreeCashFlow
21.13
Earnings Yield
0
FreeCashFlow Yield
0.08
Market Cap
10,23 Bil.
Enterprise Value
18,37 Bil.
Graham Number
21.79
Graham NetNet
-58.73

Income Statement Metrics

Net Income per Share
0.25
Income Quality
13.44
ROE
0
Return On Assets
0
Return On Capital Employed
0.05
Net Income per EBT
32.82
EBT Per Ebit
0
Ebit per Revenue
0.05
Effective Tax Rate
-31.82

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.43
Operating Profit Margin
0.05
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
6.91
Free CashFlow per Share
6.91
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
1.25
Return on Tangible Assets
0
Days Sales Outstanding
94.13
Days Payables Outstanding
108.83
Days of Inventory on Hand
115.36
Receivables Turnover
3.88
Payables Turnover
3.35
Inventory Turnover
3.16
Capex per Share
0

Balance Sheet

Cash per Share
3,68
Book Value per Share
86,04
Tangible Book Value per Share
84.96
Shareholders Equity per Share
86.04
Interest Debt per Share
71.91
Debt to Equity
0.78
Debt to Assets
0.37
Net Debt to EBITDA
5.99
Current Ratio
1.17
Tangible Asset Value
10,69 Bil.
Net Current Asset Value
-3,92 Bil.
Invested Capital
15003980000
Working Capital
1,19 Bil.
Intangibles to Total Assets
0.01
Average Receivables
1,91 Bil.
Average Payables
1,26 Bil.
Average Inventory
1336235000
Debt to Market Cap
0.82

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Bodal Chemicals Limited Dividends
Year Dividends Growth
2011 1
2015 0 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 0%
2023 0 0%

Bodal Chemicals Limited Profile

About Bodal Chemicals Limited

Bodal Chemicals Limited manufactures and sells dyestuffs, dyes intermediates, and other chemicals in India. The company's dye intermediates primarily include vinyl sulphone ester, ortho anisidine vinyl sulphone, meta ureido aniline, H. acid, Bronner's vinyl sulphone, vinyl sulphone paracresidine base, 6-nitro 1-diazo-2naphthol 4-sulphonic acid, sulpho para vinyl sulphone, sulpho tobias acid, vinyl sulphone ester of 2:5 di methoxy aniline, sulpho ortho anisidine vinyl sulphone, F.C. acid, 1:2:4 diazo, K–acid, benzedine di sulphonic acid, benzanilide vinyl sulphone, and gamma acid. It also provides reactive, acid, and direct dyes for textile, leather, and paper industries; and sulphuric acid, chloro sulphonic acid, liquid SO3, oleums, beta napthol, linear alkyl benzene sulphonic acid, and acetanilide that are used as raw materials for the production of dye intermediates. Bodal Chemicals Limited also exports its products. The company was formerly known as Dintex Dyechem Limited and changed its name to Bodal Chemicals Limited in May 2006. Bodal Chemicals Limited was incorporated in 1986 and is headquartered in Ahmedabad, India.

CEO
Mr. Sureshbhai Jayantibhai Pat
Employee
2.133
Address
Plot No. 123-124
Ahmedabad, 382445

Bodal Chemicals Limited Executives & BODs

Bodal Chemicals Limited Executives & BODs
# Name Age
1 Mr. Ashutosh Bharatkumar Bhatt
Company Secretary & Compliance Officer
70
2 Bipinbhai Chandulal Patel
Head of Production Dyestuff Division
70
3 Mr. Harjeet Singh Sandhu
Vice President
70
4 Mr. Bansibhai Maganbhai Patel
President of Production & Technical
70
5 Mr. Bhavin Suresh Patel
Executive Director
70
6 Mr. Prasad Hari Pujari
Head of Sulphuric Products Division
70
7 Mr. Ankit Sureshbhai Patel
Executive Director
70
8 Mr. Rajarshi Ghosh
Director of Health, Safety & Environment and Director
70
9 Mr. Sureshbhai Jayantibhai Patel
Chairman, MD & Chief Executive Officer
70
10 Mr. Mayur Bachubhai Padhya
Chief Financial Officer
70

Bodal Chemicals Limited Competitors